What is PRIME?

PRIME is a European consortium of research institutes, medical centres, companies, and societal stakeholders that is funded through an EU Horizon 2020 grant. From 2020 – 2024, PRIME will aim to unravel the insulin-dependent mechanisms that underly both somatic conditions (i.e. type 2 diabetes, obesity, metabolic syndrome) and brain disorders (i.e. Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders). Until now, very little attention has been paid to the role of insulin signaling in brain disorders, and the overlap (or ‘multimorbidity’) with somatic conditions.

Therefore, through PRIME, we aim to develop tools for improved diagnosis, clinical care and prevention of insulin-related lifespan multimorbidity.

Learn More

News & Events

13 November 2024

PRIME Public Event on Bridging Brain and Somatic Health – Register now to join online

On 13 November 2024, 13:45 – 15:35 PRIME hosts the session A Healthy Brain in a Healthy Body: Bridging Brain and Somatic Health at the Brain Innovation Days. Register here to join the session online. Or attend the Brain Innovation Days to join in person.

The increasing number of people living with two or more chronic disorders (multi-morbidities) poses an urgent need to better understand underlying mechanisms for better prevention and care throughout the life course. Somatic disorders (e.g., type 2 diabetes) and brain disorders (e.g., Alzheimer’s disorder) often co-occur. This session aims to explore the link between mental and non-mental disorders and how to better address it in clinical practice and medical education.

The event is hosted by prof. Barbara Franke (PRIME coordinator) and Marina Koussathana (Project Advisor). In session 1, prof. Andreas Reif and prof. Henrik Larsson discuss the latest EU research bridging brain and somatic disorders. In session 2, representatives of Alzheimer Europe, IDF Europe, and ADHD Europe discuss patient perspectives on the need to integrate brain and body care. Finally in session 3, clinical guideline recommendations will be presented by dr. Alexander Häge, and the need for guidelines and medical education will be discussed with the panel.

More information can be found on https://www.braininnovationdays.eu/programme-day-1/

More News

Social media

more social media
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847879.
This website reflects only the view of the authors and the European Commission is not responsible for any use that may be made of the information it contains‍.
‍
© 2024 PRIME